1. Home
  2. NTRA vs FCNCA Comparison

NTRA vs FCNCA Comparison

Compare NTRA & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • FCNCA
  • Stock Information
  • Founded
  • NTRA 2003
  • FCNCA 1898
  • Country
  • NTRA United States
  • FCNCA United States
  • Employees
  • NTRA N/A
  • FCNCA N/A
  • Industry
  • NTRA Medical Specialities
  • FCNCA Major Banks
  • Sector
  • NTRA Health Care
  • FCNCA Finance
  • Exchange
  • NTRA Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • NTRA 24.9B
  • FCNCA 22.6B
  • IPO Year
  • NTRA 2015
  • FCNCA N/A
  • Fundamental
  • Price
  • NTRA $198.93
  • FCNCA $1,824.82
  • Analyst Decision
  • NTRA Strong Buy
  • FCNCA Buy
  • Analyst Count
  • NTRA 17
  • FCNCA 10
  • Target Price
  • NTRA $196.24
  • FCNCA $2,184.00
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • FCNCA 133.8K
  • Earning Date
  • NTRA 11-06-2025
  • FCNCA 10-23-2025
  • Dividend Yield
  • NTRA N/A
  • FCNCA 0.46%
  • EPS Growth
  • NTRA N/A
  • FCNCA N/A
  • EPS
  • NTRA N/A
  • FCNCA 169.29
  • Revenue
  • NTRA $1,964,250,000.00
  • FCNCA $8,897,000,000.00
  • Revenue This Year
  • NTRA $24.17
  • FCNCA $0.16
  • Revenue Next Year
  • NTRA $15.57
  • FCNCA $1.71
  • P/E Ratio
  • NTRA N/A
  • FCNCA $10.78
  • Revenue Growth
  • NTRA 44.38
  • FCNCA N/A
  • 52 Week Low
  • NTRA $120.67
  • FCNCA $1,473.62
  • 52 Week High
  • NTRA $199.21
  • FCNCA $2,412.93
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 73.41
  • FCNCA 55.14
  • Support Level
  • NTRA $188.06
  • FCNCA $1,735.03
  • Resistance Level
  • NTRA $198.99
  • FCNCA $1,802.95
  • Average True Range (ATR)
  • NTRA 6.85
  • FCNCA 51.69
  • MACD
  • NTRA 1.01
  • FCNCA 14.53
  • Stochastic Oscillator
  • NTRA 99.01
  • FCNCA 99.51

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: